Literature DB >> 6976862

Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

G Valesini, M Picardo, R Pastore, P Pivetti, U Serafini.   

Abstract

The C1q-binding assay was performed on 30 sera from patients with Behçet's syndrome and circulating immune complexes were found in 46%. Circulating immune complexes were isolated and purified from the sera of two patients by immunoadsorption on a column of polymethylmetacrylate beads coated with C1q and then labelled with 125I. In double immunodiffusion these purified immune complexes were found to contain IgG, C1q, C1s and C3. Anti-IgG activity was not detectable in the purified immune complexes while specific cross-reactivity was found in a solid-phase radioimmunoassay with the majority of the sera of behçet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6976862      PMCID: PMC1537329     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

3.  Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol.

Authors:  W D Creighton; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

Authors:  C Heusser; M Boesman; J H Nordin; H Isliker
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

5.  Damaged membrane fragments and immune complexes in the blood of patients with Behcet's syndrome.

Authors:  T Lehner; J D Almeida; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Circulating immune complexes in active Behçet's disease.

Authors:  R C Gupta; J D O'Duffy; F C McDuffie; M Meurer; R E Jordon
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.

Authors:  R J Levinsky; T Lehner
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

10.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

View more
  4 in total

1.  Natural killer cells in Behçet's disease.

Authors:  K Hamzaoui; K Ayed; M Hamza; J L Touraine
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

2.  Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.

Authors:  G Valesini; P Pivetti-Pezzi; F Mastrandrea; A Moncada; M Cuomo; P G Natali
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Circulating immune complexes in sera of patients infected with Echinococcus granulosus.

Authors:  C Pini; R Pastore; G Valesini
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

4.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.